Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06227845
NA
Preterm Infant Intestinal Microbiota Development and Maternal Fecal Transplant
Sponsor: Otto Helve
View on ClinicalTrials.gov
Summary
The goal of this clinical trial is to study if a oral maternal fecal transplant given to a premature infant born by cesarean section (CS) is safe. The investigators will also compare the gut microbiome of the infants to those born by CS and not received the transplant and to premature infants born vaginally.
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
36
Start Date
2024-02
Completion Date
2026-12
Last Updated
2024-02-15
Healthy Volunteers
No
Conditions
Interventions
OTHER
Fecal microbiota transplant
0.1-0.3 ml liquid containing 3.5 mg/ml of maternal fecal content, (0.35mg/kg)
Locations (1)
Helsinki University Hospital
Helsinki, Uusimaa, Finland